Is the administration of fibrinogen concentrate in patients with persistent bleeding after initial cardiac surgery associated with an increased risk of thromboembolic events or death? Authors of a Swedish observational study published last year aimed to answer this question.
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
